Injective price analysis: support level at 6.41 remains fragile

Injective is currently caught in a difficult position as market participants watch the 6.41 price floor with anxiety. For several days, buyers have attempted to defend this specific zone, hoping to prevent a deeper correction that could trigger stop loss orders across the board. However, the consistent pressure from short sellers suggests that the momentum remains firmly in favor of those betting on further downside for the asset.

The technical structure surrounding Injective shows that the asset has struggled to maintain its recent gains. Every time a recovery attempt gains traction, selling volume increases, indicating that institutional and retail traders are using minor rallies as liquidity exits rather than accumulation opportunities. This behavior creates a ceiling that prevents the token from reclaiming higher territory.

Volume analysis provides a clear picture of the current exhaustion among bullish traders. While the 6.41 level has acted as a historical pivot point in past cycles, the current lack of strong buy orders suggests that market confidence is waning. If the price closes significantly below this threshold, the next logical area for support would likely be found at lower psychological levels, potentially testing investor resolve.

Traders should monitor the order book dynamics closely over the next few sessions. A breakdown of the 6.41 support could lead to increased volatility and a rapid shift in sentiment. Conversely, if a sudden surge in buying volume appears, it would require a sustained breakout above immediate resistance to invalidate the current bearish thesis. For now, the path of least resistance appears to be downward.

Ultimately, the situation for Injective reflects the broader hesitancy seen in the altcoin market throughout 2026. Investors are prioritizing capital preservation as macroeconomic uncertainty continues to weigh on speculative assets. Until clear accumulation patterns emerge, the battle at the 6.41 mark serves as a sobering reminder of how quickly market sentiment can turn against even well established projects.